|
22.01.2025 07:00:24
|
SKAN announces preliminary key figures for the 2024 financial year
|
SKAN AG / Key word(s): Preliminary Results Ad hoc announcement pursuant to Art. 53 LR
Allschwil, 22 January 2025 – The SKAN Group AG, world market leader for high-quality isolator systems for aseptic production processes in the (bio-) pharmaceutical industry, expects based on preliminary, not yet audited figures net sales of around CHF 360 million (2023: CHF 320.0 million) and earnings before interest, taxes, depreciation and amortization (EBITDA) of around CHF 56 million (2023: CHF 50.1 million). Order intake is expected to reach around CHF 360 million (2023: CHF 295.1 million).
SKAN Group AG will publish the detailed 2024 financial results on Tuesday, March 25, 2025, at 7:00 a.m. At the same time, the 2024 Annual Report and the 2024 year-end presentation will be available for download at www.skan.com. An investor, analyst and media conference is also planned for 10:00 a.m. at the Widder Hotel in Zurich. Further details will be provided in due course.
Contacts: Thomas Balmer, ir@skan.com, +41 79 703 87 28
SKAN – together always one step ahead SKAN is a pioneer in the field of aseptic and aseptic-toxic manufacturing processes for the (bio)pharmaceutical industry. The company is the market and technology leader for high-quality, process-critical isolator systems for filling drugs according to strict sterility standards. In addition, the company offers its customers process support, services and consumables. Innovative solutions and an efficient life-cycle support organisation make SKAN an important partner for the pharmaceutical and biotech industry, CMOs (Contract Manufacturing Organisations) and research laboratories worldwide. Founded in 1968, SKAN today employs approximately 1400 people. More than half of them work at the Allschwil headquarters in the Life Sciences Hub of the Basel region. The other employees are located among the subsidiaries in Switzerland, Germany, Belgium, Japan, the USA and Brazil. End of Inside Information |
| Language: | English |
| Company: | SKAN AG |
| Kreuzstrasse 5 | |
| 4123 Allschwil | |
| Switzerland | |
| Phone: | +41 43 268 32 32 |
| E-mail: | info@skan.com |
| ISIN: | CH0013396012 |
| Valor: | 1339601 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2072065 |
| End of Announcement | EQS News Service |
|
|
2072065 22-Jan-2025 CET/CEST
Nachrichten zu SKAN
|
07:00 |
SKAN gibt provisorische Eckwerte zum Jahresergebnis 2024 be-kannt (EQS Group) | |
|
07:00 |
SKAN announces preliminary key figures for the 2024 financial year (EQS Group) | |
|
07.01.25 |
Dienstagshandel in Zürich: SPI verliert zum Start des Dienstagshandels (finanzen.ch) | |
|
02.01.25 |
SPI-Papier SKAN-Aktie: So viel hätten Anleger mit einem Investment in SKAN von vor 3 Jahren verloren (finanzen.ch) | |
|
26.12.24 |
SPI-Wert SKAN-Aktie: So viel Verlust wäre bei einem Investment in SKAN von vor einem Jahr angefallen (finanzen.ch) | |
|
18.12.24 |
Börse Zürich in Rot: SPI schliesst in der Verlustzone (finanzen.ch) | |
|
18.12.24 |
Anleger in Zürich halten sich zurück: SPI gibt nachmittags nach (finanzen.ch) | |
|
05.12.24 |
SPI-Titel SKAN-Aktie: So viel Verlust hätte eine SKAN-Investition von vor 3 Jahren eingebracht (finanzen.ch) |
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ LPL Finance
✅ Blackstone
✅ Ares Management
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| SKAN | 80.50 | 1.13% |
|
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Trump-Effekt hält an: SMI im Plus -- DAX deutlich höher - neues Rekordhoch -- Asiens Börsen letztlich mehrheitlich in RotDer heimische sowie der deutsche Aktienmarkt zeigen sich am Mittwoch mit Gewinnen. Der DAX erreicht dabei sogar eine neue Bestmarke. Die Börsen in Fernost notierten zur Wochenmitte überwiegend im Minus.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |